background

Bortezomib Ester Impurity

Bortezomib Ester Impurity Watermark

Bortezomib Ester Impurity

CAT No:CL-BTZ-71
CAS No:NA
Mol.F:C29H39BN4O4
Mol.Wt.:518.5
Chemical Name:N-(1-((3-methyl-1-(3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
Inventory Status:Custom synthesis

This impurity is related to Bortezomib Ester Impurity is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.

Bortezomib Ester Impurity is used as a reference standard in analytical research. It ensures consistency of formulations.

Chemical Name:N-(1-((3-methyl-1-(3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
Country of Origin: India
Product Category: Impurity Reference Standard
API NAME: Bortezomib
Molecular Formula: C29H39BN4O4
Molecular Weight: 518.5
Storage: Store in a cool, dry place.

Document